In an ideal situation, these humanized mice would reject foreign stem cells just as a human patient would.
Wu shares senior authorship of the research, which was published Aug. 22 in Cell Reports, with Dale Greiner, PhD, professor in the Program in Molecular Medicine at the University of Massachusetts Medical School, and Leonard Shultz, PhD, professor at the Jackson Laboratory. Former postdoctoral scholars Nigel Kooreman, MD, and Patricia de Almeida, PhD, and graduate student Jonathan Stack, DVM, share lead authorship of the study.
Although these mice are fully functional in their immune response to HIV infection or after transplantation of other tissues, they are unable to completely reject the stem cells, said Kooreman. Understanding why this is, and whether we can overcome this deficiency, is a critical step in advancing stem cell therapies in humans.
Humanized mice are critical preclinical models in many biomedical fields helping to bring basic science into the clinic, but as this work shows, it is critical to frame the question properly, said Greiner. Multiple laboratories remain committed to advancing our understanding and enhancing the function of engrafted human immune systems.
Greiner and Shultz helped to pioneer the use of humanized mice in the 1990s to model human diseases and they provided the mice used in the study.
The researchers were studying pluripotent stem cells, which can become any tissue in the body. They tested the animals immune response to human embryonic stem cells, which are naturally pluripotent, and to induced pluripotent stem cells. Although iPS cells can be made from a patients own tissues, future clinical applications will likely rely on pre-screened, FDA-approved banks of stem cell-derived products developed for specific clinical situations, such as heart muscle cells to repair tissue damaged by a heart attack, or endothelial cells to stimulate new blood vessel growth. Unlike patient-specific iPS cells, these cells would be reliable and immediately available for clinical use. But because they wont genetically match each patient, its likely that they would be rejected without giving the recipients immunosuppressive drugs.
Humanized mice were first developed in the 1980s. Researchers genetically engineered the mice to be unable to develop their own immune system. They then used human immune and bone marrow precursor cells to reconstitute the animals immune system. Over the years subsequent studies have shown that the human immune cells survive better when fragments of the human thymus and liver are also implanted into the animals.
Kooreman and his colleagues found that two varieties of humanized mice were unable to completely reject unrelated human embryonic stem cells or iPS cells, despite the fact that some human immune cells homed to and were active in the transplanted stem cell grafts. In some cases, the cells not only thrived, but grew rapidly to form cancers called teratomas. In contrast, mice with unaltered immune systems quickly dispatched both forms of human pluripotent stem cells.
The researchers obtained similar results when they transplanted endothelial cells derived from the pluripotent stem cells.
To understand more about what was happening, Kooreman and his colleagues created a new mouse model similar to the humanized mice. Instead of reconstituting the animals nonexistent immune systems with human cells, however, they used immune and bone marrow cells from a different strain of mice. They then performed the same set of experiments again.
Unlike the humanized mice, these new mice robustly rejected human pluripotent stem cells as well as mouse stem cells from a genetically mismatched strain of mice. In other words, their newly acquired immune systems appeared to be in much better working order.
Although more research needs to be done to identify the cause of the discrepancy between the two types of animals, the researchers speculate it may have something to do with the complexity of the immune system and the need to further optimize the humanized mouse model to perhaps include other types of cells or signaling molecules. In the meantime, they are warning other researchers of potential pitfalls in using this model to screen for immunosuppressive drugs that could be effective after human stem cell transplants.
Many in the fields of pluripotent stem cell research and regenerative medicine are pushing the use of the humanized mice to study the human immune response, said Kooreman. But if we start to make claims using this model, assuming that these cells wont be rejected by patients, it could be worrisome. Our work clearly shows that, although there is some human immune cell activity, these animals dont fully reconstitute the human immune system.
The researchers are hopeful that recent advances may overcome some of the current models limitations.
The immune system is highly complex and there still remains much we need to learn, said Shultz. Each roadblock we identify will only serve as a landmark as we navigate the future. Already, weve seen recent improvements inhumanized mousemodels that foster enhancement of human immune function.
Wu is a member of Stanford Bio-X, the Stanford Cancer Institute and the Stanford Child Health Research Institute. He is also the Simon H. Stertzer Professor.
Additional Stanford co-authors are former research assistant Raman Nelakanti; former postdoctoral scholars Sebastian Diecke, PhD, and Veronica Sanchez-Freire, PhD; postdoctoral scholar Ning-Yi Shao, MD, PhD; instructor Elena Matsa, PhD; and associate professor of pathology Andrew Connolly, MD, PhD.
The research was funded by the California Institute of Regenerative Medicine, the National Institutes of Health (grants R01HL132875, R01HL133272, P30CA034196, UC4DK104218 and T32OD01112) and the Helmsley Charitable Trust.
Stanfords Department of Medicine also supported the work.
Go here to see the original:
Mouse model of human immune system inadequate for stem cell studies - Stanford Medical Center Report
- Stem Cell Therapy Market by Treatment,Application,End Users and Geography Forecast To 2026 - Markets Gazette 24 - November 11th, 2019
- Global Stem Cell Assay Market 2019 Size, Share, Growth, Trends, Type, Application, Analysis and Forecast by 2026 - Markets Gazette 24 - November 11th, 2019
- Oct4, Considered Vital for Creating iPSCs, Actually Isnt Needed - The Scientist - November 8th, 2019
- A winding romp through advances in cell biology pushes readers to ponder the boundaries of life - Science Magazine - October 31st, 2019
- Cell Banking Outsourcing Market to 2027 - Global Analysis and Forecasts By Product Type (Cord Cell Banking, Adult Stem Cell Banking, Embryonic Stem... - October 31st, 2019
- Cell Isolation Market ||Becton, Dickinson, and Company, Thermo Fisher Scientific, Inc., Merck KGaA - Industry News Info - October 31st, 2019
- Scientists Made Mice Live 12% Longer by Hacking Their Telomeres - Futurism - October 22nd, 2019
- Scientists extend mice lifespan 12% by tweaking telomeres - Big Think - October 22nd, 2019
- Merck KGaA opens Shanghai Innovation Center and invests $ 14 million in the China Seed Fund - asume tech - October 19th, 2019
- Health policy will be the focus of the HLTH - asume tech - October 19th, 2019
- Syros sees strategic shift after the failure of the previously promising cancer drug - asume tech - October 19th, 2019
- What Theranos Whistleblowers Learn About Ethics in Health Startups - asume tech - October 19th, 2019
- Assessments of Treatment Options for Age-related Macular Degeneration - DocWire News - October 15th, 2019
- Stem Cells Market Growth Rate, Production Volume and Future Opportunities From 2019-2024 - Exponent Online - October 15th, 2019
- Catholics more motivated to donate if ethical investing is assured - Crux: Covering all things Catholic - October 10th, 2019
- Greenwood to step down as CEO of BIO after 2020 election - FierceBiotech - October 10th, 2019
- Epigenetic initiation of the TH17 differentiation program is promoted by Cxxc finger protein 1 - Science Advances - October 10th, 2019
- Interview with Tamer Mohamed of Aspect Biosystems on Advancing Tissue Therapeutics - 3DPrint.com - October 10th, 2019
- Yale researchers develop way to help brain organoids thrive - Yale News - October 9th, 2019
- Catholics more motivated to donate if ethical investing is assured - The Catholic Spirit - October 9th, 2019
- Stem Cell Market: By Key Players, Market Competitive Landscape, Trends and Forecasts to 2024 - Joliet Observer - October 9th, 2019
- Stem Cell Therapy Market to Witness a Pronounce Growth During 2020 - Gem Newz - October 9th, 2019
- On creativity, plasticity and repentance - Arutz Sheva - October 5th, 2019
- What's in the cards for this year's Nobel Prizes? - STAT - October 2nd, 2019
- Moving beyond hype: Could one-two treatment restore damaged heart muscle? - University of Wisconsin-Madison - September 28th, 2019
- Conjugated polymers optically regulate the fate of endothelial colony-forming cells - Science Advances - September 28th, 2019
- God of miniscule things - Pune Mirror - September 27th, 2019
- New study shows insight into how cells maintain their identity - Drug Target Review - September 24th, 2019
- Human Embryonic Stem Cells Market: Expansion Strategies Set to Generate Substantial Revenue in the near Future - Rapid News Network - September 24th, 2019
- Global Stem Cells Market 2019 Strategic Assessment by Top Players CCBC, Vcanbio, Boyalife, Beikebiotech - News Coed - September 24th, 2019
- Study Gives Clues to the Origin of Huntington's Disease, and a New Way to Find Drugs - Nature World News - September 24th, 2019
- Global Stem Cells Market 2019 Business Statistics Focus Report Growth by Top Key Players CCBC, Vcanbio, Boyalife, Beikebiotec - The Industry News... - September 24th, 2019
- Orthopedic Biomaterials Product Market Set to Witness YoY Growth by 2018-2026 - NewsStoner - September 24th, 2019
- Global Fetal Bovine Serum Market : Industry Analysis and Forecast (2017-2026) - OnYourDesks - September 24th, 2019
- Stem Cell Therapy Market to Discern Steadfast Expansion During 2020 - Technology Trend - September 24th, 2019
- Embryonic Stem Cell - an overview | ScienceDirect Topics - May 22nd, 2019
- Embryonic Stem Cell Research and Vaccines using Fetal Tissue - May 6th, 2019
- Embryonic Stem Cells - Definitions, Use, and Research - April 28th, 2019
- Will Embryonic Stem Cells Ever Cure Anything? - MIT ... - April 28th, 2019
- Creating Embryonic Stem Cells Without Embryo Destruction - April 23rd, 2019
- What Are Stem Cells? - livescience.com - April 19th, 2019
- Embryonic Stem-Cell Research Reaches Moral, Medical Dead End - April 8th, 2019
- Embryonic Stem Cell: Definition, Uses and Collection ... - April 2nd, 2019
- Advantages of Embryonic Stem Cell Research | Sciencing - March 30th, 2019
- Practical Problems with Embryonic Stem Cells - usccb.org - March 20th, 2019
- Obama Ends Stem Cell Research Ban - CBS News - March 10th, 2019
- Types of Stem Cells A Closer Look at Stem Cells - January 26th, 2019
- Embryonic Stem Cell Research - rtlofneo.com - December 19th, 2018
- The Ethics Of Embryonic Stem Cell Research Viewpoint Essay - December 11th, 2018
- Embryonic Stem Cells and Artificial Stem Cells Are ... - December 5th, 2018
- Embryonic stem cells | Cells | MCAT | Khan Academy - November 25th, 2018
- Crucial Differences Between Non-Embryonic and Embryonic Stem ... - November 23rd, 2018
- 14 Key Pros and Cons of Embryonic Stem Cell Research ... - November 5th, 2018
- Human Embryonic Stem Cells in Development, Volume 129 ... - September 29th, 2018
- Reprogrammed stem cells identical to embryonic stem cells - September 29th, 2018
- Embryonic Stem Cell Protocols by Kursad Turksen | Waterstones - September 29th, 2018
- What Are Stem Cells? Research, Transplant, Therapy, Definition - July 17th, 2018
- Embryonic Stem Cell Research Pros and Cons | HRFnd - June 19th, 2018
- Stem Cell Research: Is It in Danger? - September 29th, 2017
- Truth About Embryonic Stem Cells | Stem Cell Orthopedic ... - September 29th, 2017
- Embryonic Stem Cell Research Still Hasn't Cured a Single ... - September 25th, 2017
- Doubts raised about CRISPR gene-editing study in human embryos - Nature.com - September 2nd, 2017
- Study shows human stem cells restore mobility in Parkinson's monkeys - Borneo Bulletin Online - September 2nd, 2017
- Sofa Vergara's ex might finally be out of luck in his battle for custody ... - Slate Magazine (blog) - September 1st, 2017
- Young cardiac cells rejuvenate heart in animal study - The San Diego Union-Tribune - August 29th, 2017
- embryonic stem cells : NPR - August 25th, 2017
- Injections of Vitamin C Could Help Fight Blood Cancer - Wall Street Pit - August 25th, 2017
- Letter: Response to 'Disappointed by Republicans' - The Herald-News - August 20th, 2017
- What are Embryonic Stem Cells? - amaskincare.com - August 19th, 2017
- Woman Will Use Stem Cells From Her Baby's Umbilical Cord To ... - LifeNews.com - August 19th, 2017
- Stem cells mimic sphere where embryos grow - Futurity: Research News - August 19th, 2017
- Vitamin C helps genes to kill off cells that would cause cancer - New Scientist - August 19th, 2017
- A way to stabilize haploidy in animal cells - Phys.Org - August 16th, 2017
- First implants derived from stem cells to 'cure' type 1 diabetes - New Scientist - August 12th, 2017
- Fast facts about cloning - WPSD Local 6: Your news, weather, and sports authority - WPSD Local 6 - August 12th, 2017
- Stem Cell Implant Is Being Trialled To Cure" Type 1 Diabetes - IFLScience - August 12th, 2017
- Lego-Like Brain Balls Could Build a Living Replica of Your Noggin - WIRED - August 12th, 2017
- Amniotic sac in a dish: Stem cells form structures that may aid of infertility research - Phys.Org - August 8th, 2017
- BioTech Marketing and market opportunity for Stem Cells - Checkbiotech.org (press release) - August 8th, 2017
- Stem Cell Training and Top Protocols using Human Umbilical Cell Tissue - Checkbiotech.org (press release) - August 8th, 2017